ମହିଳାଙ୍କ କ୍ୟାନ୍ସର
Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୧ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative …
ପ୍ରାୟୋଜକ: ଟାଟା ମେଡିକାଲ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT06816836
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 29 ମେ 2025 · ଆମ ଦ୍ୱାରା 20 ଅକ୍ଟୋବର 2026 ରେ ପଢାଯାଇଛି